| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |